<SEC-DOCUMENT>0001193125-26-140137.txt : 20260402
<SEC-HEADER>0001193125-26-140137.hdr.sgml : 20260402
<ACCEPTANCE-DATETIME>20260402161507
ACCESSION NUMBER:		0001193125-26-140137
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260331
FILED AS OF DATE:		20260402
DATE AS OF CHANGE:		20260402

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Lin Yu-Hsin
		CENTRAL INDEX KEY:			0001965964
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41359
		FILM NUMBER:		26833674

	MAIL ADDRESS:	
		STREET 1:		12750 HIGH BLUFF DRIVE, SUITE 475
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER NAME:	
		FORMER CONFORMED NAME:	LIn Yu-Hsin
		DATE OF NAME CHANGE:	20230215

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BELITE BIO, INC
		CENTRAL INDEX KEY:			0001889109
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		12750 HIGH BLUFF DRIVE SUITE 475
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		858-246-6240

	MAIL ADDRESS:	
		STREET 1:		12750 HIGH BLUFF DRIVE SUITE 475
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0609</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2026-03-31</periodOfReport>

    <notSubjectToSection16>false</notSubjectToSection16>

    <issuer>
        <issuerCik>0001889109</issuerCik>
        <issuerName>BELITE BIO, INC</issuerName>
        <issuerTradingSymbol>BLTE</issuerTradingSymbol>
        <issuerForeignTradingSymbol></issuerForeignTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001965964</rptOwnerCik>
            <rptOwnerName>Lin Yu-Hsin</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerNonUSAddressFlag>false</rptOwnerNonUSAddressFlag>
            <rptOwnerStreet1>12750 HIGH BLUFF DRIVE, SUITE 475</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>SAN DIEGO</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>92130</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>true</isDirector>
            <isOfficer>true</isOfficer>
            <isTenPercentOwner>false</isTenPercentOwner>
            <isOther>false</isOther>
            <officerTitle>Chief Executive Officer</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>false</aff10b5One>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0.4386</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2026-03-31</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>false</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>206954</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <value>2026-03-31</value>
            </exerciseDate>
            <expirationDate>
                <value>2030-12-22</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Ordinary  Shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>206954</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>413908</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">On December 23, 2020, the reporting person was granted an option which shall vest in installments upon satisfaction of certain performance criteria. 206,954 ordinary shares subject to the option that had previously vested  remain exercisable. One of the performance criteria was met on 3/31/2026, resulting in vesting of the option as to additional 206,954 ordinary shares.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Yu-Hsin Lin</signatureName>
        <signatureDate>2026-04-02</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
